Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo.

Dai, Yun

Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo. [electronic resource] - International journal of cancer Jun 2008 - 2858-63 p. digital

Publication Type: Journal Article

1097-0215

10.1002/ijc.23443 doi


Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Caspase 3--metabolism
Cell Division--drug effects
Cell Line, Tumor
Colonic Neoplasms--pathology
Down-Regulation
Humans
In Situ Nick-End Labeling
PPAR gamma--antagonists & inhibitors
Rosiglitazone
Thiazolidinediones--pharmacology
X-Linked Inhibitor of Apoptosis Protein--metabolism